Terms: = Breast cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Staging
4 results:
1. Development of a Rare Earth Nanoprobe Enables In Vivo Real-Time Detection of Sentinel Lymph Node Metastasis of breast cancer Using NIR-IIb Imaging.
Zhu YY; Song L; Zhang YQ; Liu WL; Chen WL; Gao WL; Zhang LX; Wang JZ; Ming ZH; Zhang Y; Zhang GJ
Cancer Res; 2023 Oct; 83(20):3428-3441. PubMed ID: 37540231
[TBL] [Abstract] [Full Text] [Related]
2. Examination of methylation changes of
Shirkavand A; Boroujeni ZN; Aleyasin SA
Indian J Cancer; 2018; 55(4):366-371. PubMed ID: 30829272
[TBL] [Abstract] [Full Text] [Related]
3. Molecular markers for breast cancer: prediction on tumor behavior.
Banin Hirata BK; Oda JM; Losi Guembarovski R; Ariza CB; de Oliveira CE; Watanabe MA
Dis Markers; 2014; 2014():513158. PubMed ID: 24591761
[TBL] [Abstract] [Full Text] [Related]
4. Molecular imaging of cxcr4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography.
Nimmagadda S; Pullambhatla M; Stone K; Green G; Bhujwalla ZM; Pomper MG
Cancer Res; 2010 May; 70(10):3935-44. PubMed ID: 20460522
[TBL] [Abstract] [Full Text] [Related]
